VNIM
PRAH

Vaughan Nelson Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Vaughan Nelson Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,325
Closed -$203K – 212
2021
Q1 		$203K Sell
1,325
-639,635
-100% -$86.9M ﹤0.01% 169
2020
Q4 		$80.4M Sell
640,960
-63,060
-9% -$7.05M 0.94% 35
2020
Q3 		$71.4M Buy
704,020
+59,585
+9% +$6.08M 0.99% 33
2020
Q2 		$62.7M Sell
644,435
-109,454
-15% -$10.2M 0.9% 28
2020
Q1 		$62.6M Buy
753,889
+162,550
+27% +$15.9M 1.07% 25
2019
Q4 		$65.7M Buy
591,339
+67,925
+13% +$6.99M 0.82% 38
2019
Q3 		$51.9M Buy
523,414
+174,175
+50% +$17.3M 0.69% 48
2019
Q2 		$34.6M Buy
349,239
+62,050
+22% +$5.92M 0.46% 84
2019
Q1 		$31.7M Sell
287,189
-5,700
-2% -$596K 0.42% 95
2018
Q4 		$26.9M Sell
292,889
-40,340
-12% -$4.08M 0.39% 109
2018
Q3 		$36.7M Sell
333,229
-90,715
-21% -$9.44M 0.43% 104
2018
Q2 		$39.6M Sell
423,944
-88,125
-17% -$7.59M 0.47% 90
2018
Q1 		$42.5M Sell
512,069
-29,981
-6% -$2.66M 0.52% 87
2017
Q4 		$49.4M Sell
542,050
-14,975
-3% -$1.25M 0.57% 75
2017
Q3 		$42.4M Buy
557,025
+77,775
+16% +$5.88M 0.5% 90
2017
Q2 		$35.9M Sell
479,250
-10,175
-2% -$705K 0.43% 111
2017
Q1 		$31.9M Sell
489,425
-179,700
-27% -$10.6M 0.37% 127
2016
Q4 		$36.9M Buy
669,125
+127,475
+24% +$7M 0.44% 110
2016
Q3 		$30.6M Buy
541,650
+9,300
+2% +$456K 0.36% 124
2016
Q2 		$22.2M Sell
532,350
-37,525
-7% -$1.73M 0.28% 127
2016
Q1 		$24.4M Sell
569,875
-274,825
-33% -$11.6M 0.31% 128
2015
Q4 		$38.2M Sell
844,700
-833,950
-50% -$35M 0.49% 103
2015
Q3 		$65.2M Sell
1,678,650
-282,300
-14% -$11.3M 0.93% 35
2015
Q2 		$71.2M Buy
1,960,950
+317,700
+19% +$10M 1% 32
2015
Q1 		$47.4M Sell
1,643,250
-308,675
-16% -$8.61M 0.72% 59
2014
Q4 		$47.3M Buy
+1,951,925
New +$44M 0.69% 64

Other funds holding PRAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Vaughan Nelson Investment Management's PRAH Position: Q2 2021 in Review

Vaughan Nelson Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 1,325 shares — an estimated $203K sold.

Vaughan Nelson Investment Management first reported a position in PRAH in Q4 2014 and held it in 26 quarters. The position peaked at $80.4M in Q4 2020. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Vaughan Nelson Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Vaughan Nelson Investment Management sold 1,325 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $203K.
  • Vaughan Nelson Investment Management first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 26 quarters.
  • Vaughan Nelson Investment Management's PRA Health Sciences, Inc. position peaked at $80.4M in Q4 2020.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2021, filed 15 Jul 2021.